Court agrees with Watson's interpretation of Lidoderm patent

06/28/2011 | Wall Street Journal, The

A U.S. District Court sided with Watson Pharmaceuticals in a patent dispute involving Endo Pharmaceuticals Holdings' painkilling patch Lidoderm. Watson is seeking regulatory approval to launch a generic Lidoderm. Endo "will explore a number of different legal options, one of which could be an appeal," said Blaine Davis, vice president of corporate affairs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC